News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,390 Results
Type
Article (87260)
Company Profile (732)
Press Release (770371)
Multimedia
Podcasts (165)
Webinars (26)
Section
Business (232988)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91212)
Employer Resources (201)
FDA (18248)
Job Trends (17388)
News (397223)
Policy (39902)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (119)
Alliances (56979)
ALS (137)
Alzheimer's disease (1649)
Antibody-drug conjugate (ADC) (206)
Approvals (18245)
Artificial intelligence (459)
Autoimmune disease (49)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (150)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (47)
Breast cancer (439)
Cancer (3558)
Cardiovascular disease (312)
Career advice (3551)
Career pathing (36)
CAR-T (232)
CDC (49)
Cell therapy (633)
Cervical cancer (29)
Clinical research (74977)
Collaboration (1293)
Company closure (4)
Compensation (868)
Complete response letters (51)
COVID-19 (2941)
CRISPR (78)
C-suite (514)
Cystic fibrosis (130)
Data (3843)
Decentralized trials (2)
Denatured (59)
Depression (101)
Diabetes (429)
Diagnostics (7052)
Digital health (30)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (216)
Drug pricing (169)
Drug shortages (36)
Duchenne muscular dystrophy (183)
Earnings (98644)
Editorial (53)
Employer branding (25)
Employer resources (169)
Events (132460)
Executive appointments (958)
FDA (20504)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1144)
Gene editing (165)
Generative AI (45)
Gene therapy (500)
GLP-1 (1002)
Government (5350)
Grass and pollen (7)
Guidances (334)
Healthcare (20934)
HIV (48)
Huntington's disease (34)
IgA nephropathy (52)
Immunology and inflammation (226)
Immuno-oncology (18)
Indications (47)
Infectious disease (3160)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (168)
Interviews (815)
IPO (17922)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (70)
Layoffs (628)
Leadership (31)
Legal (10144)
Liver cancer (90)
Longevity (12)
Lung cancer (512)
Lymphoma (251)
Machine learning (23)
Management (65)
Manufacturing (576)
MASH (121)
Medical device (14832)
Medtech (14850)
Mergers & acquisitions (22679)
Metabolic disorders (1089)
Multiple sclerosis (120)
NASH (23)
Neurodegenerative disease (186)
Neuropsychiatric disorders (50)
Neuroscience (2561)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (542)
Opinion (304)
Ovarian cancer (114)
Pain (156)
Pancreatic cancer (147)
Parkinson's disease (216)
Partnered (27)
Patents (387)
Patient recruitment (272)
Peanut (57)
People (66083)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23114)
Phase II (32560)
Phase III (24504)
Pipeline (2488)
Policy (282)
Postmarket research (3554)
Preclinical (10439)
Press Release (72)
Prostate cancer (176)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (605)
Real estate (7412)
Recruiting (76)
Regulatory (27722)
Reports (64)
Research institute (2677)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (121)
Series A (190)
Series B (142)
Service/supplier (30)
Sickle cell disease (77)
Special edition (25)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (95)
Tariffs (83)
The Weekly (104)
Vaccines (1011)
Venture capital (63)
Weight loss (377)
Women's health (56)
Worklife (21)
Date
Today (93)
Last 7 days (530)
Last 30 days (2483)
Last 365 days (33909)
2025 (23929)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (298)
Arkansas (14)
Asia (50817)
Australia (8925)
California (8962)
Canada (2717)
China (849)
Colorado (379)
Connecticut (400)
Delaware (243)
Europe (116700)
Florida (1318)
Georgia (305)
Hawaii (3)
Idaho (67)
Illinois (788)
India (47)
Indiana (434)
Iowa (19)
Japan (270)
Kansas (123)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1222)
Massachusetts (6747)
Michigan (297)
Minnesota (544)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2469)
New Mexico (32)
New York (2441)
North Carolina (1367)
North Dakota (10)
Northern California (3989)
Ohio (281)
Oklahoma (19)
Oregon (49)
Pennsylvania (1865)
Puerto Rico (18)
Rhode Island (44)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3412)
Tennessee (142)
Texas (1402)
United States (33230)
Utah (268)
Virginia (239)
Washington D.C. (82)
Washington State (771)
West Virginia (4)
Wisconsin (92)
There are 858,390 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
September 19, 2025
·
9 min read
Press Releases
Innovent Announces Mazdutide Received Approval from China’s NMPA for Glycemic Control in Adults with Type 2 Diabetes
September 19, 2025
·
14 min read
Press Releases
DarwinCell Showcases novel MSC-based drug ALT001 at the 150th American Neurological Association Annual Meeting
September 19, 2025
·
3 min read
Press Releases
Genflow Strengthens IP Portfolio
September 19, 2025
·
5 min read
Press Releases
Faron Pharmaceuticals Ltd: Exercise of Options, Director Dealing and Issue of Equity
September 19, 2025
·
4 min read
Press Releases
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
September 19, 2025
·
5 min read
Press Releases
Idorsia’s JERAYGO (aprocitentan) approved in Switzerland for the treatment of resistant hypertension
September 19, 2025
·
9 min read
Press Releases
2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment
September 19, 2025
·
8 min read
Press Releases
Health Canada approves Celltrion’s Stoboclo® and Osenvelt®(CT-P41), denosumab biosimilars for the treatment of all indications approved for the reference products, Prolia® and Xgeva®, respectively
September 19, 2025
·
5 min read
Press Releases
AusperBio Completes Enrollment in Two Phase II Clinical Trials of AHB-137 for Chronic Hepatitis B
September 19, 2025
·
3 min read
1 of 85,839
Next
